Skip to main content
Clinical Trials/NCT01258413
NCT01258413
Completed
Phase 3

Laparoscopic vs Abdominal Radical Hysterectomy With Pelvic Lymphadenectomy in Patients With Early Cervical Cancer: A Randomized Clinical Trial

Hospital Nossa Senhora da Conceicao1 site in 1 country30 target enrollmentNovember 1999

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Cervical Cancer
Sponsor
Hospital Nossa Senhora da Conceicao
Enrollment
30
Locations
1
Primary Endpoint
postoperative pain measured by a 10 point numeric rating scale
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to determine whether laparoscopic radical hysterectomy for early cervical cancer will has decreased postoperative pain intensity compared to abdominal radical hysterectomy with similar postoperative complications and survival rates.

Detailed Description

Background: Radical hysterectomy with pelvic lymphadenectomy is one of the FIGO (International Federation of Gynecology and Obstetrics) recommended treatments for early cervical cancer. The objective of this study was to compare radical hysterectomy by laparoscopic approach and open radical hysterectomy in a single center randomized clinical trial. Nevertheless, there are no finished randomized controlled trials comparing laparoscopic radical hysterectomy and abdominal radical hysterectomy although there is an ongoing trial. Methods: Were enrolled 30 IA2 with lymph vascular space invasion and IB cervical cancer patients. Postoperative pain intensity was defined as primary endpoint and pain intensity was measured by a 10-point numeric rating scale. Secondary outcomes were: intraoperative and other postoperative outcomes, histopathological outcomes and 5-year follow-up. Data analysis is being done at this moment

Registry
clinicaltrials.gov
Start Date
November 1999
End Date
February 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women of 18 years or older referred to our service with histologically confirmed primary squamous, adenocarcinoma or adenosquamous cervical cancer diagnosed by biopsy or cervical conization, clinically FIGO (International Federation of Gynecologic and Obstetrics) staged IA2 with lymph vascular invasion, IB and II A.

Exclusion Criteria

  • Patients with clinically advanced disease (IIB-IV), previous pelvic or abdominal radiotherapy, pregnancy, clinical diseases that would preclude one or both surgical approaches.

Outcomes

Primary Outcomes

postoperative pain measured by a 10 point numeric rating scale

Time Frame: around one week

The primary outcome is postoperative pain as measured by a 10-point numeric rating scale (NRS) during the postoperative period. Pain was assessed every six hours by nursing staff during a patient's usual postoperative care. The nursing staff was not aware of the study objective.

Secondary Outcomes

  • Intraoperative, perioperative and postoperative complication(30 days or five years)
  • Surgicopathological outcomes(postoperatively)
  • Overall survival and disease-free survival(five years)

Study Sites (1)

Loading locations...

Similar Trials